Skip to main content
Erschienen in: Journal of Neural Transmission 11/2018

10.04.2018 | Neurology and Preclinical Neurological Studies - Review Article

90 years of monoamine oxidase: some progress and some confusion

verfasst von: Keith F. Tipton

Erschienen in: Journal of Neural Transmission | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

It would not be practical to attempt to deal with all the advances that have informed our understanding of the behavior and functions of this enzyme over the past 90 years. This account concentrates key advances that explain why the monoamine oxidases remain of pharmacological and biochemical interest and on some areas of continuing uncertainty. Some issues that remain to be understood or are in need of further clarification are highlighted.
Literatur
Zurück zum Zitat Alemany R, Olmos G, García-Sevilla JA (1997) Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes. Naunyn Schmiedebergs Arch Pharmacol 356:39–47. https://doi.org/10.1007/pl00005026 CrossRefPubMed Alemany R, Olmos G, García-Sevilla JA (1997) Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes. Naunyn Schmiedebergs Arch Pharmacol 356:39–47. https://​doi.​org/​10.​1007/​pl00005026 CrossRefPubMed
Zurück zum Zitat Ansari KS, Yu PH, Kruck TP, Tatton WG (1993) Rescue of axotomized immature rat facial motoneurons by R(−)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition. J Neurosci 13:4042–4053PubMedPubMedCentral Ansari KS, Yu PH, Kruck TP, Tatton WG (1993) Rescue of axotomized immature rat facial motoneurons by R(−)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition. J Neurosci 13:4042–4053PubMedPubMedCentral
Zurück zum Zitat Bach AW, Lan NC, Johnson DL, Abell CW, Bembenek ME, Kwan SW, Seeburg PH, Shih JC (1988) cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc Natl Acad Sci USA 85:4934–4938PubMedPubMedCentral Bach AW, Lan NC, Johnson DL, Abell CW, Bembenek ME, Kwan SW, Seeburg PH, Shih JC (1988) cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc Natl Acad Sci USA 85:4934–4938PubMedPubMedCentral
Zurück zum Zitat Barwell CJ, Ebrahimi SA (1994) Some kinetic properties of guinea pig liver monoamine oxidase. J Neural Transm Suppl 41:41–45PubMed Barwell CJ, Ebrahimi SA (1994) Some kinetic properties of guinea pig liver monoamine oxidase. J Neural Transm Suppl 41:41–45PubMed
Zurück zum Zitat Baudhuin P, Beaufay H, Rahman-Li Y, Sellinger OZ, Wattiaux R, Jacques P, De Duve C (1964) Tissue fractionation studies. 17. Intracellular distribution of monoamine oxidase, aspartate aminotransferase, alanine aminotransferase, d-amino acid oxidase and catalase in rat-liver tissue. Biochem J 92:184–205. https://doi.org/10.1042/bj0920179 CrossRefPubMedPubMedCentral Baudhuin P, Beaufay H, Rahman-Li Y, Sellinger OZ, Wattiaux R, Jacques P, De Duve C (1964) Tissue fractionation studies. 17. Intracellular distribution of monoamine oxidase, aspartate aminotransferase, alanine aminotransferase, d-amino acid oxidase and catalase in rat-liver tissue. Biochem J 92:184–205. https://​doi.​org/​10.​1042/​bj0920179 CrossRefPubMedPubMedCentral
Zurück zum Zitat Ben Ramadan Z, Tipton KF (2012) Suicide inhibition of monoamine oxidase from different species by milacemide. Jordan J Biol Sci 5:209–214 Ben Ramadan Z, Tipton KF (2012) Suicide inhibition of monoamine oxidase from different species by milacemide. Jordan J Biol Sci 5:209–214
Zurück zum Zitat Berlin I, Zimmer R, Thiede HM, Payan C, Hergueta T, Robin L, Puech AJ (1990) Comparison of monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects. Br J Clin Pharmacol 30:805–816PubMedPubMedCentral Berlin I, Zimmer R, Thiede HM, Payan C, Hergueta T, Robin L, Puech AJ (1990) Comparison of monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects. Br J Clin Pharmacol 30:805–816PubMedPubMedCentral
Zurück zum Zitat Bieck PR, Antonin KH (1988) Oral tyramine pressor test and the safety of monoamine oxidase inhibitor drugs: comparison of brofaromine and tranylcypromine in healthy subjects. J Clin Psychopharmacol 8:237–245PubMed Bieck PR, Antonin KH (1988) Oral tyramine pressor test and the safety of monoamine oxidase inhibitor drugs: comparison of brofaromine and tranylcypromine in healthy subjects. J Clin Psychopharmacol 8:237–245PubMed
Zurück zum Zitat Callingham BA (1989) Biochemical aspects of the pharmacology of moclobemide. The implications of animal studies. Br J Psychiatry (Suppl. 6):53–60 (Abstract) Callingham BA (1989) Biochemical aspects of the pharmacology of moclobemide. The implications of animal studies. Br J Psychiatry (Suppl. 6):53–60 (Abstract)
Zurück zum Zitat Callingham BA, Mazel P, Porter JC (1985) Some properties of amine oxidase activities in the rat intestine. Br J Pharmacol 86(Suppl):553P (Abstract) Callingham BA, Mazel P, Porter JC (1985) Some properties of amine oxidase activities in the rat intestine. Br J Pharmacol 86(Suppl):553P (Abstract)
Zurück zum Zitat Carpéné C, Collon P, Remaury A, Cordi A, Hudson A, Nutt D, Lafontan M (1995) Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites. J Pharmacol Exp Ther 272:681–688PubMed Carpéné C, Collon P, Remaury A, Cordi A, Hudson A, Nutt D, Lafontan M (1995) Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites. J Pharmacol Exp Ther 272:681–688PubMed
Zurück zum Zitat Coelho Cerqueira E, Netz PA, Diniz C, Petry do Canto V, Follmer C (2011) Molecular insights into human monoamine oxidase (MAO) inhibition by 1,4-naphthoquinone: evidences for menadione (vitamin K3) acting as a competitive and reversible inhibitor of MAO. Bioorg Med Chem 19:1724–7416. https://doi.org/10.1016/j.bmc.2011.10.049 CrossRef Coelho Cerqueira E, Netz PA, Diniz C, Petry do Canto V, Follmer C (2011) Molecular insights into human monoamine oxidase (MAO) inhibition by 1,4-naphthoquinone: evidences for menadione (vitamin K3) acting as a competitive and reversible inhibitor of MAO. Bioorg Med Chem 19:1724–7416. https://​doi.​org/​10.​1016/​j.​bmc.​2011.​10.​049 CrossRef
Zurück zum Zitat Curet O, Damoiseau G, Aubin N, Sontag N, Rovei V, Jarreau FX (1996) Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. I. Biochemical profile. J Pharmacol Exp Ther 277:253–264PubMed Curet O, Damoiseau G, Aubin N, Sontag N, Rovei V, Jarreau FX (1996) Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. I. Biochemical profile. J Pharmacol Exp Ther 277:253–264PubMed
Zurück zum Zitat Da Prada M, Zurcher G, Wurthrich I, Haefely WE (1988) On tyramine, food beverages and the reversible MAO inhibitor moclobemide. J Neural Transm 26(Suppl):33–56 Da Prada M, Zurcher G, Wurthrich I, Haefely WE (1988) On tyramine, food beverages and the reversible MAO inhibitor moclobemide. J Neural Transm 26(Suppl):33–56
Zurück zum Zitat Da Prada M, Kettler R, Keller HH, Cesura AM, Richards JG, Saura Marti J, Muggli-Maniglio D, Wyss PC, Kyburz E, Imhof R (1990) From moclobemide to Ro 19-6327 and Ro 41-1049: the development of a new class of reversible, selective MAO-A and MAO-B inhibitors. J Neural Transm Suppl 29:279–292PubMed Da Prada M, Kettler R, Keller HH, Cesura AM, Richards JG, Saura Marti J, Muggli-Maniglio D, Wyss PC, Kyburz E, Imhof R (1990) From moclobemide to Ro 19-6327 and Ro 41-1049: the development of a new class of reversible, selective MAO-A and MAO-B inhibitors. J Neural Transm Suppl 29:279–292PubMed
Zurück zum Zitat De Girolamo LA, Hargreaves AJ, Billett EE (2001) Protection from MPTP-induced neurotoxicity in differentiating mouse N2a neuroblastoma cells. J Neurochem 76:650–660PubMed De Girolamo LA, Hargreaves AJ, Billett EE (2001) Protection from MPTP-induced neurotoxicity in differentiating mouse N2a neuroblastoma cells. J Neurochem 76:650–660PubMed
Zurück zum Zitat Dostert PL (1984) Myth and reality of the classical MAO inhibitors, reasons for seeking a new generation. In: Tipton KF, Dostert P, Strolin Benedetti M (eds) Monoamine oxidase and disease. Academic Press, London, pp 487–497 (Book chapter) Dostert PL (1984) Myth and reality of the classical MAO inhibitors, reasons for seeking a new generation. In: Tipton KF, Dostert P, Strolin Benedetti M (eds) Monoamine oxidase and disease. Academic Press, London, pp 487–497 (Book chapter)
Zurück zum Zitat Dostert PL, Strolin Benedetti M, Tipton KF (1989) Interactions of monoamine oxidase with substrates and inhibitors. Med Res Rev 9:45–89PubMed Dostert PL, Strolin Benedetti M, Tipton KF (1989) Interactions of monoamine oxidase with substrates and inhibitors. Med Res Rev 9:45–89PubMed
Zurück zum Zitat Erwin VG, Deitrich RA (1971) The labeling in vivo of monoamine oxidase by 14 C-pargyline: a tool for studying the synthesis of the enzyme. Mol Pharmacol 7:219–228PubMed Erwin VG, Deitrich RA (1971) The labeling in vivo of monoamine oxidase by 14 C-pargyline: a tool for studying the synthesis of the enzyme. Mol Pharmacol 7:219–228PubMed
Zurück zum Zitat Finberg JP (2014) Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release. Pharmacol Ther 143:133–152PubMed Finberg JP (2014) Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release. Pharmacol Ther 143:133–152PubMed
Zurück zum Zitat Fowler CJ Strolin, Benedetti M (1983) Cimoxatone is a reversible tight-binding inhibitor of the A form of rat brain monoamine oxidase. J Neurochem 40:510–513PubMed Fowler CJ Strolin, Benedetti M (1983) Cimoxatone is a reversible tight-binding inhibitor of the A form of rat brain monoamine oxidase. J Neurochem 40:510–513PubMed
Zurück zum Zitat Fowler CJ, Oreland L (1981) Substrate- and stereoselective inhibitor of human brain monoamine oxidase by 4-dimethylamino-alpha, 2-dimethylphenethylamine (FLA 336). J Pharm Pharmacol 33:403–406PubMed Fowler CJ, Oreland L (1981) Substrate- and stereoselective inhibitor of human brain monoamine oxidase by 4-dimethylamino-alpha, 2-dimethylphenethylamine (FLA 336). J Pharm Pharmacol 33:403–406PubMed
Zurück zum Zitat Fowler CJ, Mantle TJ, Tipton KF (1982) The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline. Biochem Pharmacol 3:3555–3561 Fowler CJ, Mantle TJ, Tipton KF (1982) The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline. Biochem Pharmacol 3:3555–3561
Zurück zum Zitat Fowler JS, Volkow ND, Logan J, Wang GJ, MacGregor RR, Schlyer D et al (1994) Slow recovery of human brain MAO B after l-deprenyl (Selegiline) withdrawal. Synapse 18:86–93PubMed Fowler JS, Volkow ND, Logan J, Wang GJ, MacGregor RR, Schlyer D et al (1994) Slow recovery of human brain MAO B after l-deprenyl (Selegiline) withdrawal. Synapse 18:86–93PubMed
Zurück zum Zitat Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C, Alexoff D, MacGregor RR, Schlyer DJ, Zezulkova I, Wolf AP (1996) Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci USA 93:14065–14069PubMedPubMedCentral Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C, Alexoff D, MacGregor RR, Schlyer DJ, Zezulkova I, Wolf AP (1996) Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci USA 93:14065–14069PubMedPubMedCentral
Zurück zum Zitat Fowler JS, Logan J, Wang GJ, Volkow ND, Telang F, Zhu W, Franceschi D et al (2003) Low monoamine oxidase B in peripheral organs in smokers. Proc Natl Acad Sci USA 100:11600–11605PubMedPubMedCentral Fowler JS, Logan J, Wang GJ, Volkow ND, Telang F, Zhu W, Franceschi D et al (2003) Low monoamine oxidase B in peripheral organs in smokers. Proc Natl Acad Sci USA 100:11600–11605PubMedPubMedCentral
Zurück zum Zitat Fuller RW, Hemrick SK (1978) Steric influence on inhibition of monoamine oxidase forms by 2,3-dichloro-alpha-methylbenzylamine. Res Commun Chem Pathol Pharmacol 20:199–202PubMed Fuller RW, Hemrick SK (1978) Steric influence on inhibition of monoamine oxidase forms by 2,3-dichloro-alpha-methylbenzylamine. Res Commun Chem Pathol Pharmacol 20:199–202PubMed
Zurück zum Zitat Gandal MJ, Haney JR, Parikshak NN, Leppa V, Ramaswami G, Hartl C, Schork AJ, Appadurai V, Buil A, Werge TM, Liu C, White KP; CommonMind Consortium; PsychENCODE Consortium; iPSYCH-BROAD Working Group, Horvath S, Geschwind DH (2018) Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science 359:693–697. https://doi.org/10.1126/science.aad6469 PubMedPubMedCentral Gandal MJ, Haney JR, Parikshak NN, Leppa V, Ramaswami G, Hartl C, Schork AJ, Appadurai V, Buil A, Werge TM, Liu C, White KP; CommonMind Consortium; PsychENCODE Consortium; iPSYCH-BROAD Working Group, Horvath S, Geschwind DH (2018) Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science 359:693–697. https://​doi.​org/​10.​1126/​science.​aad6469 PubMedPubMedCentral
Zurück zum Zitat Gareri P, Falconi U, De Fazio P, De Sarro G (2000) Conventional and new antidepressant drugs in the elderly. Progr Neurobiol 61:353–396 Gareri P, Falconi U, De Fazio P, De Sarro G (2000) Conventional and new antidepressant drugs in the elderly. Progr Neurobiol 61:353–396
Zurück zum Zitat Gärtner B, Hemmerich P, Zeller EA (1976) Structure of flavin adducts with acetylenic substrates. Chemistry of monoamine oxidase and lactate oxidase inhibition. Eur J Biochem 63:211–221PubMed Gärtner B, Hemmerich P, Zeller EA (1976) Structure of flavin adducts with acetylenic substrates. Chemistry of monoamine oxidase and lactate oxidase inhibition. Eur J Biochem 63:211–221PubMed
Zurück zum Zitat Gerlach M, Youdim MB, Riederer P (1996) Pharmacology of selegiline. Neurology 47(9 Suppl 3):S137–S145PubMed Gerlach M, Youdim MB, Riederer P (1996) Pharmacology of selegiline. Neurology 47(9 Suppl 3):S137–S145PubMed
Zurück zum Zitat Gessa GL, Cuenca E, Costa E (1963) On the mechanism of the hypotensive effects of MAO inhibitors. Ann NY Acad Sci 107:935–941PubMed Gessa GL, Cuenca E, Costa E (1963) On the mechanism of the hypotensive effects of MAO inhibitors. Ann NY Acad Sci 107:935–941PubMed
Zurück zum Zitat Green AR, Mitchell D, Todoff A, Youdim MBH (1977) Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition necessary for increased functional activity of dopamine and 5-hydroxytryptamine. Br J Pharmacol 60:343–349PubMedPubMedCentral Green AR, Mitchell D, Todoff A, Youdim MBH (1977) Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition necessary for increased functional activity of dopamine and 5-hydroxytryptamine. Br J Pharmacol 60:343–349PubMedPubMedCentral
Zurück zum Zitat Guimarães JT, Vindis C, Soares-da-Silva P, Parini A (2003) Differential substrate specificity of monoamine oxidase in the rat heart and renal cortex. Life Sci 73:955–967PubMed Guimarães JT, Vindis C, Soares-da-Silva P, Parini A (2003) Differential substrate specificity of monoamine oxidase in the rat heart and renal cortex. Life Sci 73:955–967PubMed
Zurück zum Zitat Hasan F, McCrodden JM, Kennedy NP, Tipton KF (1988) The involvement of intestinal monoamine oxidase in the transport and metabolism of tyramine. J Neural Transm Suppl 26:1–9PubMed Hasan F, McCrodden JM, Kennedy NP, Tipton KF (1988) The involvement of intestinal monoamine oxidase in the transport and metabolism of tyramine. J Neural Transm Suppl 26:1–9PubMed
Zurück zum Zitat Horwitz D, Sjoerdsma A (1963) A basis for the use of monoamine oxidase inhibitors in angina pectoris. Ann NY Acad Sci 107:1033–1042PubMed Horwitz D, Sjoerdsma A (1963) A basis for the use of monoamine oxidase inhibitors in angina pectoris. Ann NY Acad Sci 107:1033–1042PubMed
Zurück zum Zitat Houtsmuller EJ, Thornton JA, Stitzer M (2002) Effects of selegiline (l-deprenyl) during smoking and short-term abstinence. Psychopharmacology 163:213–220PubMed Houtsmuller EJ, Thornton JA, Stitzer M (2002) Effects of selegiline (l-deprenyl) during smoking and short-term abstinence. Psychopharmacology 163:213–220PubMed
Zurück zum Zitat Huebner CF, Donoghue EM, Plummer AJ, Furness PA (1966) N-methyl-n-2-propynyl-l-indanamine. A potent monoamine oxidase inhibitor. J Med Chem 9:830–832PubMed Huebner CF, Donoghue EM, Plummer AJ, Furness PA (1966) N-methyl-n-2-propynyl-l-indanamine. A potent monoamine oxidase inhibitor. J Med Chem 9:830–832PubMed
Zurück zum Zitat Huszti Z (1972) Kinetic studies on rat brain monoamine oxidase. Mol Pharmacol 8:385–897PubMed Huszti Z (1972) Kinetic studies on rat brain monoamine oxidase. Mol Pharmacol 8:385–897PubMed
Zurück zum Zitat Inoue H, Castagnoli K, Van Der Schyf C, Mabic S, Igarashi K, Castagnoli N Jr (1999) Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives. J Pharmacol Exp Ther 291:856–864PubMed Inoue H, Castagnoli K, Van Der Schyf C, Mabic S, Igarashi K, Castagnoli N Jr (1999) Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives. J Pharmacol Exp Ther 291:856–864PubMed
Zurück zum Zitat Kelsoe JR, Ginns EI, Egeland JA, Gerhard DS, Goldstein AM, Bale SJ, Pauls DL, Long RT, Kidd KK, Conte G et al (1989) Re-evaluation of the linkage relationship between chromosome 11p loci and the gene for bipolar affective disorder in the Old Order Amish. Nature 342:238–243. https://doi.org/10.1038/342238a0 CrossRefPubMed Kelsoe JR, Ginns EI, Egeland JA, Gerhard DS, Goldstein AM, Bale SJ, Pauls DL, Long RT, Kidd KK, Conte G et al (1989) Re-evaluation of the linkage relationship between chromosome 11p loci and the gene for bipolar affective disorder in the Old Order Amish. Nature 342:238–243. https://​doi.​org/​10.​1038/​342238a0 CrossRefPubMed
Zurück zum Zitat Kinemuchi H, Fowler CJ, Tipton KF (1987) The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine (MPTP) and its relevance to Parkinson’s disease. Neurochem Int 11:359–373PubMed Kinemuchi H, Fowler CJ, Tipton KF (1987) The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine (MPTP) and its relevance to Parkinson’s disease. Neurochem Int 11:359–373PubMed
Zurück zum Zitat Kline NS (1958) Clinical experience with iproniazid (Marsilid). J Clin Exp Psychopathol 19(Suppl. 1):72–78 (discussion 78–79) PubMed Kline NS (1958) Clinical experience with iproniazid (Marsilid). J Clin Exp Psychopathol 19(Suppl. 1):72–78 (discussion 78–79) PubMed
Zurück zum Zitat Knoll J, Magyar K (1972) Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv Biochem Psychopharmacol 5:393–408PubMed Knoll J, Magyar K (1972) Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv Biochem Psychopharmacol 5:393–408PubMed
Zurück zum Zitat Knoll J, Miklya I (1994) Multiple, small dose administration of (−)deprenyl enhances catecholaminergic activity and diminishes serotoninergic activity in the brain and these effects are unrelated to MAO-B inhibition. Arch Int Pharmacodyn Ther 328:1–15PubMed Knoll J, Miklya I (1994) Multiple, small dose administration of (−)deprenyl enhances catecholaminergic activity and diminishes serotoninergic activity in the brain and these effects are unrelated to MAO-B inhibition. Arch Int Pharmacodyn Ther 328:1–15PubMed
Zurück zum Zitat Knoll J, Ecsery Z, Magyar K, Sátory E (1978) Novel (−)deprenyl-derived selective inhibitors of B-type monoamine oxidase. The relation of structure to their action. Biochem Pharmacol 27:1739–1747PubMed Knoll J, Ecsery Z, Magyar K, Sátory E (1978) Novel (−)deprenyl-derived selective inhibitors of B-type monoamine oxidase. The relation of structure to their action. Biochem Pharmacol 27:1739–1747PubMed
Zurück zum Zitat Kragten E, Lalande I, Zimmermann K, Roggo S, Schindler P, Muller D, van Oostrum J, Waldmeier P, Furst P (1998) Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(−)-deprenyl. J Biol Chem 273:5821–5828PubMed Kragten E, Lalande I, Zimmermann K, Roggo S, Schindler P, Muller D, van Oostrum J, Waldmeier P, Furst P (1998) Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(−)-deprenyl. J Biol Chem 273:5821–5828PubMed
Zurück zum Zitat Long RF, Mantle TJ, Wilson K (1976) Substrate-selective inhibition of monoamine oxidase by some cyclopropylamino substituted oxadiazoles. Biochem Pharmacol 25:247–252PubMed Long RF, Mantle TJ, Wilson K (1976) Substrate-selective inhibition of monoamine oxidase by some cyclopropylamino substituted oxadiazoles. Biochem Pharmacol 25:247–252PubMed
Zurück zum Zitat Macedo D, Filho AJMC, Soares de Sousa CN, Quevedo J, Barichello T, Júnior HVN, Freitas de Lucena D (2017) Antidepressants, antimicrobials or both? Gut microbiota symbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness. J Affect Disord 208:22–32. https://doi.org/10.1016/j.jad.2016.09.012 CrossRefPubMed Macedo D, Filho AJMC, Soares de Sousa CN, Quevedo J, Barichello T, Júnior HVN, Freitas de Lucena D (2017) Antidepressants, antimicrobials or both? Gut microbiota symbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness. J Affect Disord 208:22–32. https://​doi.​org/​10.​1016/​j.​jad.​2016.​09.​012 CrossRefPubMed
Zurück zum Zitat Marconi S, Zwingers T (2014) Comparative efficacy of selegiline versus rasagiline in the treatment of early Parkinson’s disease. Eur Rev Med Pharmacol Sci 18:1879–1882PubMed Marconi S, Zwingers T (2014) Comparative efficacy of selegiline versus rasagiline in the treatment of early Parkinson’s disease. Eur Rev Med Pharmacol Sci 18:1879–1882PubMed
Zurück zum Zitat Maruyama W, Boulton AA, Davis BA, Dostert P, Naoi M (2001) Enantio-specific induction of apoptosis by an endogenous neurotoxin N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells: suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine. J Neural Transm 108:11–24PubMed Maruyama W, Boulton AA, Davis BA, Dostert P, Naoi M (2001) Enantio-specific induction of apoptosis by an endogenous neurotoxin N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells: suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine. J Neural Transm 108:11–24PubMed
Zurück zum Zitat Marzo A, Dal Bo L, Monti NC, Crivelli F, Ismaili S, Caccia C, Cattaneo C, Fariello RG (2004) Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity. Pharmacol Res 50:77–85PubMed Marzo A, Dal Bo L, Monti NC, Crivelli F, Ismaili S, Caccia C, Cattaneo C, Fariello RG (2004) Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity. Pharmacol Res 50:77–85PubMed
Zurück zum Zitat Matveychuk D, Nunes E, Ullah N, Aldawsari FS, Velázquez-Martínez CA, Baker GB (2014) Elevation of rat brain tyrosine levels by phenelzine is mediated by its active metabolite β-phenylethylidenehydrazine. Prog Neuropsychopharmacol Biol Psychiatry 53:67–73PubMed Matveychuk D, Nunes E, Ullah N, Aldawsari FS, Velázquez-Martínez CA, Baker GB (2014) Elevation of rat brain tyrosine levels by phenelzine is mediated by its active metabolite β-phenylethylidenehydrazine. Prog Neuropsychopharmacol Biol Psychiatry 53:67–73PubMed
Zurück zum Zitat McEwen CM Jr, Sasaki G, Lenz WR Jr (1968) Human liver mitochondrial monoamine oxidase. I. Kinetic studies of model interactions. J Biol Chem 243:5217–5225PubMed McEwen CM Jr, Sasaki G, Lenz WR Jr (1968) Human liver mitochondrial monoamine oxidase. I. Kinetic studies of model interactions. J Biol Chem 243:5217–5225PubMed
Zurück zum Zitat Meda F, Rampon C, Dupont E, Gauron C, Mourton A, Queguiner I, Thauvin M, Volovitch M, Joliot A, Vriz S (2017) Nerves, H2O2 and Shh: three players in the game of regeneration. Semin Cell Dev Biol S1084–9521(17):30448–30502 Meda F, Rampon C, Dupont E, Gauron C, Mourton A, Queguiner I, Thauvin M, Volovitch M, Joliot A, Vriz S (2017) Nerves, H2O2 and Shh: three players in the game of regeneration. Semin Cell Dev Biol S1084–9521(17):30448–30502
Zurück zum Zitat Medvedev AE, Glover V (2004) Tribulin and endogenous MAO-inhibitory regulation in vivo. Neurotoxicology 25:185–192PubMed Medvedev AE, Glover V (2004) Tribulin and endogenous MAO-inhibitory regulation in vivo. Neurotoxicology 25:185–192PubMed
Zurück zum Zitat Medvedev A, Igosheva N, Crumeyrolle-Arias M, Glover V (2005) Isatin: role in stress and anxiety. Stress 8:175–183PubMed Medvedev A, Igosheva N, Crumeyrolle-Arias M, Glover V (2005) Isatin: role in stress and anxiety. Stress 8:175–183PubMed
Zurück zum Zitat Mihalik J, Kravcuková P, Spakovská T, Mareková M, Schmidtová K (2008) Study of high deprenyl dose on the preimplantation embryo development and lymphocyte DNA in rat. Gen Physiol Biophys 27:121–126PubMed Mihalik J, Kravcuková P, Spakovská T, Mareková M, Schmidtová K (2008) Study of high deprenyl dose on the preimplantation embryo development and lymphocyte DNA in rat. Gen Physiol Biophys 27:121–126PubMed
Zurück zum Zitat Miller JR, Edmondson DE (1999) Influence of flavin analogue structure on the catalytic activities and flavinylation reactions of recombinant human liver monoamine oxidases A and B. J Biol Chem 274:23515–23525PubMed Miller JR, Edmondson DE (1999) Influence of flavin analogue structure on the catalytic activities and flavinylation reactions of recombinant human liver monoamine oxidases A and B. J Biol Chem 274:23515–23525PubMed
Zurück zum Zitat Murphy S, Pastuszko A (1994) Effect of neurocatin on the activity of monoamine oxidase B in rat brain synaptosomes. Neurochem Res 19:177–182PubMed Murphy S, Pastuszko A (1994) Effect of neurocatin on the activity of monoamine oxidase B in rat brain synaptosomes. Neurochem Res 19:177–182PubMed
Zurück zum Zitat Murphy DL, Donnelly CH, Richelson E, Fuller RW (1978) N-substituted cyclopropylamines as inhibitors of MAO-A and -B forms. Biochem Pharmacol 27:1767–17699PubMed Murphy DL, Donnelly CH, Richelson E, Fuller RW (1978) N-substituted cyclopropylamines as inhibitors of MAO-A and -B forms. Biochem Pharmacol 27:1767–17699PubMed
Zurück zum Zitat Mytilineou C, Leonardi EK, Radcliffe P, Heinonen EH, Han SK, Werner P, Cohen G, Olanow CW (1998) Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion. J Pharmacol Exp Ther 284:700–706PubMed Mytilineou C, Leonardi EK, Radcliffe P, Heinonen EH, Han SK, Werner P, Cohen G, Olanow CW (1998) Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion. J Pharmacol Exp Ther 284:700–706PubMed
Zurück zum Zitat Naoi M, Ishiki R, Nomura Y, Hasegawa S, Nagatsu T (1987) Quinolinic acid: an endogenous inhibitor specific for type B monoamine oxidase in human brain synaptosomes. Neurosci Lett 74:232–236PubMed Naoi M, Ishiki R, Nomura Y, Hasegawa S, Nagatsu T (1987) Quinolinic acid: an endogenous inhibitor specific for type B monoamine oxidase in human brain synaptosomes. Neurosci Lett 74:232–236PubMed
Zurück zum Zitat Naoi M, Maruyama W, Sasuga S, Deng Y, Dostert P, Ohta S, Takahashi T (1994) Inhibition of type A monoamine oxidase by 2(N)-methyl-6,7-dihydroxyisoquinolinium ions. Neurochem Int 25:475–481PubMed Naoi M, Maruyama W, Sasuga S, Deng Y, Dostert P, Ohta S, Takahashi T (1994) Inhibition of type A monoamine oxidase by 2(N)-methyl-6,7-dihydroxyisoquinolinium ions. Neurochem Int 25:475–481PubMed
Zurück zum Zitat Naoi M, Muruyama W, Dostert P, Hashizume Y, Nakahara D, Takahashi T, Ota M (1996) Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl-(R-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioural studies. Brain Res 709:285–295. https://doi.org/10.1016/0006-8993(95)01325-3 CrossRefPubMed Naoi M, Muruyama W, Dostert P, Hashizume Y, Nakahara D, Takahashi T, Ota M (1996) Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl-(R-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioural studies. Brain Res 709:285–295. https://​doi.​org/​10.​1016/​0006-8993(95)01325-3 CrossRefPubMed
Zurück zum Zitat Neff NH, Goridis C (1972) Neuronal monoamine oxidase: specific enzyme types and their rates of formation. Adv Biochem Psychopharmacol 5:307–323PubMed Neff NH, Goridis C (1972) Neuronal monoamine oxidase: specific enzyme types and their rates of formation. Adv Biochem Psychopharmacol 5:307–323PubMed
Zurück zum Zitat Nelson SD, Mitchell JR, Snodgrass WR, Timbrell JA (1978) Hepatotoxicity and metabolism of iproniazid and isopropylhydrazine. J Pharmacol Exp Ther 206:574–585PubMed Nelson SD, Mitchell JR, Snodgrass WR, Timbrell JA (1978) Hepatotoxicity and metabolism of iproniazid and isopropylhydrazine. J Pharmacol Exp Ther 206:574–585PubMed
Zurück zum Zitat Nelson DL, Herber A, Petillot Y, Pichat L, Glowinski J, Hamon M (1979) [3H]-Harmaline as a specific ligand for MAO-A from rat and bovine brains. J Neurochem 32:1817–1827PubMed Nelson DL, Herber A, Petillot Y, Pichat L, Glowinski J, Hamon M (1979) [3H]-Harmaline as a specific ligand for MAO-A from rat and bovine brains. J Neurochem 32:1817–1827PubMed
Zurück zum Zitat Nic a’ Bháird N, McCrodden M, Wheatley AM, Harrington MC, Sullivan Sullivan, Tipton KF (1990) Determination of amines, amine metabolites and some amine metabolizing enzymes by high performance liquid chromatography. Biomed Chromatogr 4:229–233PubMed Nic a’ Bháird N, McCrodden M, Wheatley AM, Harrington MC, Sullivan Sullivan, Tipton KF (1990) Determination of amines, amine metabolites and some amine metabolizing enzymes by high performance liquid chromatography. Biomed Chromatogr 4:229–233PubMed
Zurück zum Zitat O’Carroll AM, Tipton KF, Sullivan JP, Fowler CJ, Ross SB (1987) Intra- and extrasynaptosomal deamination of dopamine and noradrenaline by the two forms of human brain monoamine oxidase. Implications for the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in man. Biog Amines 4:165–178 O’Carroll AM, Tipton KF, Sullivan JP, Fowler CJ, Ross SB (1987) Intra- and extrasynaptosomal deamination of dopamine and noradrenaline by the two forms of human brain monoamine oxidase. Implications for the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in man. Biog Amines 4:165–178
Zurück zum Zitat O’Carroll AM, Anderson MC, Tobbia I, Phillips JP, Tipton KF (1989) Determination of the absolute concentrations of monoamine oxidase A and B in human tissues. Biochem Pharmacol 38:901–905PubMed O’Carroll AM, Anderson MC, Tobbia I, Phillips JP, Tipton KF (1989) Determination of the absolute concentrations of monoamine oxidase A and B in human tissues. Biochem Pharmacol 38:901–905PubMed
Zurück zum Zitat Oreland L (2004) Platelet monoamine oxidase. Personality and alcoholism: the rise, fall and resurrection. Neurotoxicology 25:79–89PubMed Oreland L (2004) Platelet monoamine oxidase. Personality and alcoholism: the rise, fall and resurrection. Neurotoxicology 25:79–89PubMed
Zurück zum Zitat Orologas AG, Buckman TD (1986) A comparison of platelet monoamine oxidase activity and phosphatidylserine content between chronic paranoid schizophrenics and normal controls. Neurosci Lett 88:293–298 Orologas AG, Buckman TD (1986) A comparison of platelet monoamine oxidase activity and phosphatidylserine content between chronic paranoid schizophrenics and normal controls. Neurosci Lett 88:293–298
Zurück zum Zitat Orru R, Aldeco M, Edmondson DE (2013) Do MAO A and MAO B utilize the same mechanism for the C–H bond cleavage step in catalysis? Evidence suggesting differing mechanisms. J Neural Transm 120:847–851PubMedPubMedCentral Orru R, Aldeco M, Edmondson DE (2013) Do MAO A and MAO B utilize the same mechanism for the C–H bond cleavage step in catalysis? Evidence suggesting differing mechanisms. J Neural Transm 120:847–851PubMedPubMedCentral
Zurück zum Zitat Oxenkrug GF (1999) Antidepressive and antihypertensive effects of MAO-A inhibition: role of N-acetylserotonin. A review. Neurobiology 7:213–224 (Book Chapter) PubMed Oxenkrug GF (1999) Antidepressive and antihypertensive effects of MAO-A inhibition: role of N-acetylserotonin. A review. Neurobiology 7:213–224 (Book Chapter) PubMed
Zurück zum Zitat Parkinson Study Group (1996) Effect of lazabemide on the progression of disability in early Parkinson’s disease. Ann Neurol 40:99–107 Parkinson Study Group (1996) Effect of lazabemide on the progression of disability in early Parkinson’s disease. Ann Neurol 40:99–107
Zurück zum Zitat Patek DR, Hellerman L (1974) Mitochondrial monoamine oxidase. Mechanism of inhibition by phenylhydrazine and by aralkylhydrazines. Role of enzymatic oxidation. J Biol Chem 249:2373–2380PubMed Patek DR, Hellerman L (1974) Mitochondrial monoamine oxidase. Mechanism of inhibition by phenylhydrazine and by aralkylhydrazines. Role of enzymatic oxidation. J Biol Chem 249:2373–2380PubMed
Zurück zum Zitat Rebsam A, Seif I, Gaspar P (2005) Dissociating barrel development and lesion-induced plasticity in the mouse somatosensory cortex. J Neurosci 25:706–710PubMedPubMedCentral Rebsam A, Seif I, Gaspar P (2005) Dissociating barrel development and lesion-induced plasticity in the mouse somatosensory cortex. J Neurosci 25:706–710PubMedPubMedCentral
Zurück zum Zitat Reid AA, Hill JL, Murphy DL (1988) Interactions of tricyclic antidepressant drugs with human and rat monoamine oxidase type B. Naunyn Schmiedebergs Arch Pharmacol 338:678–683PubMed Reid AA, Hill JL, Murphy DL (1988) Interactions of tricyclic antidepressant drugs with human and rat monoamine oxidase type B. Naunyn Schmiedebergs Arch Pharmacol 338:678–683PubMed
Zurück zum Zitat Riederer P, Lachenmayer L (2003) Selegiline’s neuroprotective capacity revisited. J. Neural Transm 110:1273–1278PubMed Riederer P, Lachenmayer L (2003) Selegiline’s neuroprotective capacity revisited. J. Neural Transm 110:1273–1278PubMed
Zurück zum Zitat Rommelspacher H, May T, Salewski B (1994) Harman (1-methyl-beta-carboline) is a natural inhibitor of monoamine oxidase type A in rats. Eur J Pharmacol 252:51–59PubMed Rommelspacher H, May T, Salewski B (1994) Harman (1-methyl-beta-carboline) is a natural inhibitor of monoamine oxidase type A in rats. Eur J Pharmacol 252:51–59PubMed
Zurück zum Zitat Rose RM, Castellani S, Boeringa JA, Malek-Ahmadi P, Lankford DA, Bessman JD, Fritz RR, Denney CB, Denney RM, Abell CW (1986) Platelet MAO concentration and molecular activity: II. Comparison of normal and schizophrenic populations. Psychiatr Res 17:141–151 Rose RM, Castellani S, Boeringa JA, Malek-Ahmadi P, Lankford DA, Bessman JD, Fritz RR, Denney CB, Denney RM, Abell CW (1986) Platelet MAO concentration and molecular activity: II. Comparison of normal and schizophrenic populations. Psychiatr Res 17:141–151
Zurück zum Zitat Sandler M, Glover V, Clow A, Elsworth JD (1985) Tribulin: an endogenous monoamine oxidase inhibitor/benzodiazepine receptor ligand. Prog Clin Biol Res 192:359–362PubMed Sandler M, Glover V, Clow A, Elsworth JD (1985) Tribulin: an endogenous monoamine oxidase inhibitor/benzodiazepine receptor ligand. Prog Clin Biol Res 192:359–362PubMed
Zurück zum Zitat Schlappi B (1985) The lack of hepatotoxicity in the rat with the new reversible MAO-A inhibitor moclobemide in contrast to iproniazid. Arzneimittel Forschung (Drug Research) 35:800–803 Schlappi B (1985) The lack of hepatotoxicity in the rat with the new reversible MAO-A inhibitor moclobemide in contrast to iproniazid. Arzneimittel Forschung (Drug Research) 35:800–803
Zurück zum Zitat Schoerlin MP, Da Prada M (1990) Species-specific biotransformation of moclobemide: a comparative study in rats and humans. Acta Psychiatr Scand Suppl 360:108–110PubMed Schoerlin MP, Da Prada M (1990) Species-specific biotransformation of moclobemide: a comparative study in rats and humans. Acta Psychiatr Scand Suppl 360:108–110PubMed
Zurück zum Zitat Schweitzer JW, Friedhoff AJ, Schwartz R (1975) Letter: chocolate, beta-phenethylamine and migraine re-examined. Nature 257:256PubMed Schweitzer JW, Friedhoff AJ, Schwartz R (1975) Letter: chocolate, beta-phenethylamine and migraine re-examined. Nature 257:256PubMed
Zurück zum Zitat Sen NP (1969) Analysis and significance of tyramine in foods. J Food Sci 34:22–26 Sen NP (1969) Analysis and significance of tyramine in foods. J Food Sci 34:22–26
Zurück zum Zitat Seymour CB, Mothersill C, Mooney R, Moriarty M, Tipton KF (2003) Monoamine oxidase inhibitors l-deprenyl and clorgyline protect nonmalignant human cells from ionising radiation and chemotherapy toxicity. Br J Cancer 89:1979–1986PubMedPubMedCentral Seymour CB, Mothersill C, Mooney R, Moriarty M, Tipton KF (2003) Monoamine oxidase inhibitors l-deprenyl and clorgyline protect nonmalignant human cells from ionising radiation and chemotherapy toxicity. Br J Cancer 89:1979–1986PubMedPubMedCentral
Zurück zum Zitat Shih JC (2004) Cloning, after cloning, knock-out mice, and physiological functions of MAO A and B. Neurotoxicology 25:21–30PubMed Shih JC (2004) Cloning, after cloning, knock-out mice, and physiological functions of MAO A and B. Neurotoxicology 25:21–30PubMed
Zurück zum Zitat Silverman RB, Zieske PA (1985) Mechanism of inactivation of monoamine oxidase by 1-phenylcyclopropylamine. Biochemistry 24:2128–2138PubMed Silverman RB, Zieske PA (1985) Mechanism of inactivation of monoamine oxidase by 1-phenylcyclopropylamine. Biochemistry 24:2128–2138PubMed
Zurück zum Zitat Singer TP, Ramsay RR, Sonsalla PK, Nicklas WJ, Heikkila RE (1993) Biochemical mechanisms underlying MPTP-induced and idiopathic Parkinsonism. New vistas. Adv Neurol 60:300–305PubMed Singer TP, Ramsay RR, Sonsalla PK, Nicklas WJ, Heikkila RE (1993) Biochemical mechanisms underlying MPTP-induced and idiopathic Parkinsonism. New vistas. Adv Neurol 60:300–305PubMed
Zurück zum Zitat Squires RF (1972) Multiple forms of monoamine oxidase in intact mitochondria as characterized by selective inhibitors and thermal stability: a comparison of eight mammalian species. Adv Biochem Psychopharmacol 5:355–370PubMed Squires RF (1972) Multiple forms of monoamine oxidase in intact mitochondria as characterized by selective inhibitors and thermal stability: a comparison of eight mammalian species. Adv Biochem Psychopharmacol 5:355–370PubMed
Zurück zum Zitat Starlinger H (1977) An endogenous inhibitor of amine oxidase (flavine-containing) in the carotid body of the cat. Hoppe Seylers Z Physiol Chem 358:491–497PubMed Starlinger H (1977) An endogenous inhibitor of amine oxidase (flavine-containing) in the carotid body of the cat. Hoppe Seylers Z Physiol Chem 358:491–497PubMed
Zurück zum Zitat Strolin Benedetti M, Dostert P, Tipton KF (1992) Developmental aspects of the monoamine-degrading enzyme monoamine oxidase. Dev Pharmacol Ther 18:191–200PubMed Strolin Benedetti M, Dostert P, Tipton KF (1992) Developmental aspects of the monoamine-degrading enzyme monoamine oxidase. Dev Pharmacol Ther 18:191–200PubMed
Zurück zum Zitat Sullivan JP, Tipton KF (1992) Interactions of the neurotoxin MPTP and its demethylated derivative (PTP) with monoamine oxidase-B. Neurochem Res 17:791–796PubMed Sullivan JP, Tipton KF (1992) Interactions of the neurotoxin MPTP and its demethylated derivative (PTP) with monoamine oxidase-B. Neurochem Res 17:791–796PubMed
Zurück zum Zitat Swett LR, Martin WB, Taylor JD, Everett GM, Wykes AA, Gladish YC (1963) Structure-activity relations in the pargyline series. Ann N Y Acad Sci 107:891–898PubMed Swett LR, Martin WB, Taylor JD, Everett GM, Wykes AA, Gladish YC (1963) Structure-activity relations in the pargyline series. Ann N Y Acad Sci 107:891–898PubMed
Zurück zum Zitat Szutowicz A, Tomaszewicz M, Orsulak PJ (1989) Modification of substrate-inhibitor affinities of human platelet monoamine oxidase B in vitro. J Biol Chem 264:17660–17664PubMed Szutowicz A, Tomaszewicz M, Orsulak PJ (1989) Modification of substrate-inhibitor affinities of human platelet monoamine oxidase B in vitro. J Biol Chem 264:17660–17664PubMed
Zurück zum Zitat Tan AK, Weyler W, Salach JI, Singer TP (1991) Differences in substrate specificities of monoamine oxidase A from human liver and placenta. Biochem Biophys Res Commun 181:1084–1088PubMed Tan AK, Weyler W, Salach JI, Singer TP (1991) Differences in substrate specificities of monoamine oxidase A from human liver and placenta. Biochem Biophys Res Commun 181:1084–1088PubMed
Zurück zum Zitat Taylor JD, Wykes AA, Gladish YC, Martin WB (1960) New inhibitor of monoamine oxidase. Nature 187:941–942PubMed Taylor JD, Wykes AA, Gladish YC, Martin WB (1960) New inhibitor of monoamine oxidase. Nature 187:941–942PubMed
Zurück zum Zitat Tipton KF, Fowler CJ, McCrodden JM, Strolin Benedetti M (1983) The enzyme-activated irreversible inhibition of type-B monoamine oxidase by 3-(4-[(3-chlorophenyl)methoxy]phenyl)-5-[(methylamino) methyl]-2-oxazolidinone methanesulphonate (compound MD 780236) and the enzyme-catalysed oxidation of this compound as competing reactions. Biochem J 209:235–242PubMedPubMedCentral Tipton KF, Fowler CJ, McCrodden JM, Strolin Benedetti M (1983) The enzyme-activated irreversible inhibition of type-B monoamine oxidase by 3-(4-[(3-chlorophenyl)methoxy]phenyl)-5-[(methylamino) methyl]-2-oxazolidinone methanesulphonate (compound MD 780236) and the enzyme-catalysed oxidation of this compound as competing reactions. Biochem J 209:235–242PubMedPubMedCentral
Zurück zum Zitat Tipton KF, McCrodden JM, Youdim MBH (1986) Oxidation and enzyme-activated irreversible inhibition of rat liver monoamine oxidase-B by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Biochem J 240:379–383PubMedPubMedCentral Tipton KF, McCrodden JM, Youdim MBH (1986) Oxidation and enzyme-activated irreversible inhibition of rat liver monoamine oxidase-B by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Biochem J 240:379–383PubMedPubMedCentral
Zurück zum Zitat Toyoshima Y, Kinemuchi H, Kamijo K (1979) Nonexistence of a type C monoamine oxidase in rat brain. J Neurochem 32:1183–1189PubMed Toyoshima Y, Kinemuchi H, Kamijo K (1979) Nonexistence of a type C monoamine oxidase in rat brain. J Neurochem 32:1183–1189PubMed
Zurück zum Zitat Unzeta M, Castro J, Gomez N, Tipton KF (1983) Comparisons between the monoamine oxidase activities associated with mitochondria and microsomes in rat liver. M. Br J Pharmacol 80:662P (Abstract) Unzeta M, Castro J, Gomez N, Tipton KF (1983) Comparisons between the monoamine oxidase activities associated with mitochondria and microsomes in rat liver. M. Br J Pharmacol 80:662P (Abstract)
Zurück zum Zitat Upadhyay AK, Borbat PP, Wang J, Freed JH, Edmondson DE (2008) Determination of the oligomeric states of human and rat monoamine oxidases in the outer mitochondrial membrane and octyl beta-d-glucopyranoside micelles using pulsed dipolar electron spin resonance spectroscopy. Biochemistry 47:1554–1566. https://doi.org/10.1021/bi7021377 CrossRefPubMed Upadhyay AK, Borbat PP, Wang J, Freed JH, Edmondson DE (2008) Determination of the oligomeric states of human and rat monoamine oxidases in the outer mitochondrial membrane and octyl beta-d-glucopyranoside micelles using pulsed dipolar electron spin resonance spectroscopy. Biochemistry 47:1554–1566. https://​doi.​org/​10.​1021/​bi7021377 CrossRefPubMed
Zurück zum Zitat Vazquez ML, Silverman RB (1985) Revised mechanism for inactivation of mitochondrial monoamine oxidase by N-cyclopropylbenzylamine. Biochemistry 24:6538–6543PubMed Vazquez ML, Silverman RB (1985) Revised mechanism for inactivation of mitochondrial monoamine oxidase by N-cyclopropylbenzylamine. Biochemistry 24:6538–6543PubMed
Zurück zum Zitat Waldmeier PC (1993) Newer aspects of the reversible inhibitor of MAO-A and serotonin reuptake, brofaromine. Prog Neuropsychopharmacol Biol Psychiatry 17:183–198PubMed Waldmeier PC (1993) Newer aspects of the reversible inhibitor of MAO-A and serotonin reuptake, brofaromine. Prog Neuropsychopharmacol Biol Psychiatry 17:183–198PubMed
Zurück zum Zitat Weissbach H, Redfield BG, Udenfriend S (1957) Soluble monoamine oxidase; its properties and actions on serotonin. J Biol Chem 229:953–963PubMed Weissbach H, Redfield BG, Udenfriend S (1957) Soluble monoamine oxidase; its properties and actions on serotonin. J Biol Chem 229:953–963PubMed
Zurück zum Zitat Wise CD, Potkin S, Bridge P, Wyatt RJ (1979) An endogenous inhibitor of platelet MAO activity in chronic schizophrenia: failure to replicate. Am J Psychiatry 197136:1336–1337 Wise CD, Potkin S, Bridge P, Wyatt RJ (1979) An endogenous inhibitor of platelet MAO activity in chronic schizophrenia: failure to replicate. Am J Psychiatry 197136:1336–1337
Zurück zum Zitat Worland PJ, Ilett KF (1983) Intestinal contribution to the presystemic elimination of beta-phenethylamine in the rat. J Pharm Pharmacol 35:636–640PubMed Worland PJ, Ilett KF (1983) Intestinal contribution to the presystemic elimination of beta-phenethylamine in the rat. J Pharm Pharmacol 35:636–640PubMed
Zurück zum Zitat Youdim MBH, Tipton KF (2002) Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson’s disease. Parkinsonism Relat Disord 8:247–253PubMed Youdim MBH, Tipton KF (2002) Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson’s disease. Parkinsonism Relat Disord 8:247–253PubMed
Zurück zum Zitat Youdim MBH, Aronson JK, Blau K, Green AR, Grahame-Smith DG (1979) Tranylcypromine (‘Parnate’) overdose: measurement of tranylcypromine concentrations and MAO inhibitory activity and identification of amphetamines in plasm. Psychol Med 9:377–382PubMed Youdim MBH, Aronson JK, Blau K, Green AR, Grahame-Smith DG (1979) Tranylcypromine (‘Parnate’) overdose: measurement of tranylcypromine concentrations and MAO inhibitory activity and identification of amphetamines in plasm. Psychol Med 9:377–382PubMed
Zurück zum Zitat Youdim MBH, Finberg JPM, Tipton KF (1988) Monoamine oxidase. In: Trendelenburg U, Weiner N (eds) Catecholamine II. Handbook of experimental pharmacology. Springer, Berlin, pp 127–199 (Book Chapter) Youdim MBH, Finberg JPM, Tipton KF (1988) Monoamine oxidase. In: Trendelenburg U, Weiner N (eds) Catecholamine II. Handbook of experimental pharmacology. Springer, Berlin, pp 127–199 (Book Chapter)
Zurück zum Zitat Youdim MBH, Gross A, Finberg JP (2001) Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B. Br J Pharmacol 132:500–506PubMedPubMedCentral Youdim MBH, Gross A, Finberg JP (2001) Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B. Br J Pharmacol 132:500–506PubMedPubMedCentral
Zurück zum Zitat Yu PH, Davis BA (1988) Stereospecific deamination of benzylamine catalyzed by different amine oxidases. Int J Biochem 20:1197–1201PubMed Yu PH, Davis BA (1988) Stereospecific deamination of benzylamine catalyzed by different amine oxidases. Int J Biochem 20:1197–1201PubMed
Zurück zum Zitat Zhuang ZP, Marks B, McCauley RB (1992) The insertion of monoamine oxidase A into the outer membrane of rat liver mitochondria. J Biol Chem 267:591–596PubMed Zhuang ZP, Marks B, McCauley RB (1992) The insertion of monoamine oxidase A into the outer membrane of rat liver mitochondria. J Biol Chem 267:591–596PubMed
Metadaten
Titel
90 years of monoamine oxidase: some progress and some confusion
verfasst von
Keith F. Tipton
Publikationsdatum
10.04.2018
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe 11/2018
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-018-1881-5

Weitere Artikel der Ausgabe 11/2018

Journal of Neural Transmission 11/2018 Zur Ausgabe

Psychiatry and Preclinical Psychiatric Studies - Review Article

On the practical aspects of characterising monoamine oxidase inhibition in vitro

Neurology and Preclinical Neurological Studies - Review Article

The structure of monoamine oxidases: past, present, and future

Neurology and Preclinical Neurological Studies - Review Article

Kinetics, mechanism, and inhibition of monoamine oxidase

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Neurologie

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.